Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 10/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 7/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 6/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 6/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.37 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.36 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.36 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.36 |
| ▸ | GCLC | P48506 | 1/20 | 0.35 |
| ▸ | GRM8 | O00222 | 1/20 | 0.34 |
| ▸ | GRM6 | O15303 | 1/20 | 0.34 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.34 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.34 |
| ▸ | GSR | P00390 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17789223 | 1.00 | GRIK1 (0.41) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL17789224 | 0.89 | SLC1A2 (0.44) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL1158176 | 0.89 | SLC1A2 (0.44) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL1647018 | 0.83 | SLC1A2 (0.42) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL11265342 | 0.83 | SLC1A2 (0.42) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL12086544 | 0.83 | SLC1A2 (0.42) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL2405601 | 0.83 | PTGS1 (0.46) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL2729297 | 0.82 | GSR (0.47) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL11883461 | 0.82 | GSR (0.42) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL13684358 | 0.82 | PTGS1 (0.38) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118638765-A | Cystathionine beta lyase and application thereof in synthesis of thiosulfinate compounds | 山东大学 | 2024-09-13 | — | — | CN | claimed |
| US-20230263853-A1 | ECTOPARASITICIDE VETERINARY COMPOSITION | HAYNE LANE LTD (US) | 2023-08-24 | — | — | US | claimed |
| EP-4192243-A1 | ECTOPARASITICIDE VETERINARY COMPOSITION | Hayne Lane Ltd (GB) | 2023-06-14 | — | — | EP | claimed |
| CN-114916561-B | Biopesticide for preventing and treating crop pathogenic bacteria | 山东大学 | 2022-11-18 | — | — | CN | claimed |
| CN-114916561-A | Biopesticide for preventing and treating crop pathogenic bacteria | 山东大学 | 2022-08-19 | — | — | CN | claimed |
| US-9340808-B2 | Sulfur amino acid-containing composition | NISSHIN PHARMA INC. (JP) | 2016-05-17 | — | — | US | claimed |
| EP-2829611-A1 | SULFUR AMINO ACID-CONTAINING COMPOSITION | Nisshin Pharma Inc. (JP) | 2015-01-28 | — | — | EP | claimed |
| US-20150004658-A1 | SULFUR AMINO ACID-CONTAINING COMPOSITION | NISSHIN PHARMA INC. (JP) | 2015-01-01 | — | — | US | claimed |
| US-8481284-B2 | Process of preparing conjugates of allium organosulfur compounds with amino acids, peptides, and proteins | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-07-09 | — | — | US | claimed |
| US-20110082282-A1 | PROCESS OF PREPARING CONJUGATES OF ALLIUM ORGANOSULFUR COMPOUNDS WITH AMINO ACIDS, PEPTIDES, AND PROTEINS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-04-07 | — | — | US | claimed |
| US-20030105093-A1 | MTP activity-lowering compositions | YANAGITA TERUYOSHI (JP) | 2003-06-05 | — | — | US | claimed |
| EP-1080724-A1 | MTP ACTIVITY-LOWERING COMPOSITIONS | Nippon Shinyaku Co., Ltd. (JP) | 2001-03-07 | — | — | EP | claimed |
| EP-0705603-B1 | Use of non-toxic cysteine sulfoxide derivatives in the treatment of cancer | HOLT JOHN ALFRED GORTON (AU) | 2000-08-16 | — | — | EP | claimed |
| EP-0764442-A1 | Use of specific sulphur containing aminos acid derivatives against pathogenic viral or prion particles | Holt, John Alfred Gorton (AU) | 1997-03-26 | — | — | EP | claimed |
| EP-0705603-A1 | Use of non-toxic cysteine sulfoxide derivatives in the treatment of cancer or for enhancing the T-cell count | Holt, John Alfred Gorton (AU) | 1996-04-10 | — | — | EP | claimed |
| CN-122084906-A | Plasma metabolism marker for early diagnosis or prediction of gestational diabetes mellitus and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260034152-A1 | Influx Vitamins and Drinks, with Zinc Ionophoric Influx | BLACK STEPHEN (US) | 2026-02-05 | — | — | US | disclosed |
| EP-0180672-B1 | PROCESS FOR THE PRODUCTION OF FLAVOR ENHANCING SEASONINGS | AJINOMOTO CO., INC. (JP) | 1988-09-21 | — | — | EP | disclosed |
| US-4741914-A | WITH GLUTAMIC ACID SALT | AJINOMOTO CO., INC. (JP) | 1988-05-03 | — | — | US | disclosed |
| EP-0180672-A1 | Process for the production of flavor enhancing seasonings | AJINOMOTO CO., INC. (JP) | 1986-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110082282-A1 | PROCESS OF PREPARING CONJUGATES OF ALLIUM ORGANOSULFUR COMPOUNDS WITH AMINO ACIDS, PEPTIDES, AND PROTEINS | SCLY, NOTUM, TST | GRIK1 2556/4885GRIK2 1522/4885SLC1A2 462/4885 |
| US-20030105093-A1 | MTP activity-lowering compositions | MTPN, APOB, TTR | GRIK1 4386/4885GRIK2 4026/4885SLC1A2 2696/4885 |
| US-20230263853-A1 | ECTOPARASITICIDE VETERINARY COMPOSITION | NOTUM, PRMT5, ARG1 | GRIK1 856/4885GRIK2 1095/4885SLC1A2 154/4885 |
| US-20260034152-A1 | Influx Vitamins and Drinks, with Zinc Ionophoric Influx | KCNN3, VDR, KCNN2 | GRIK1 397/4885GRIK2 504/4885SLC1A2 553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.